Guangzhou LBP Medicine Science & Technology Co., Ltd. (688393.SS)
CNY 29.9
(-2.64%)
CNY 29.9
(-2.64%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 335.41 Million CNY | 31.42% |
| 2022 | 360.63 Million CNY | 5.43% |
| 2021 | 342.04 Million CNY | 14.22% |
| 2020 | 299.46 Million CNY | 0.76% |
| 2019 | 297.21 Million CNY | 16.96% |
| 2018 | 254.12 Million CNY | 16.97% |
| 2017 | 217.26 Million CNY | 9.5% |
| 2016 | 198.41 Million CNY | 0.0% |
| 2013 | 96.32 Million CNY | 37.58% |
| 2012 | 70.01 Million CNY | 22.94% |
| 2011 | 56.95 Million CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q3 | 80.39 Million CNY | 2.26% |
| 2024 Q2 | 78.61 Million CNY | 7.43% |
| 2024 Q1 | 73.18 Million CNY | -23.07% |
| 2023 Q2 | 86.96 Million CNY | 34.91% |
| 2023 FY | 473.93 Million CNY | 31.42% |
| 2023 Q1 | 64.45 Million CNY | -29.29% |
| 2023 Q4 | 95.12 Million CNY | 1.11% |
| 2023 Q3 | 94.07 Million CNY | 8.18% |
| 2022 FY | 360.63 Million CNY | 5.43% |
| 2022 Q4 | 91.16 Million CNY | -3.34% |
| 2022 Q3 | 94.31 Million CNY | 4.75% |
| 2022 Q2 | 90.03 Million CNY | 5.77% |
| 2022 Q1 | 85.11 Million CNY | -1.75% |
| 2021 Q1 | 77.18 Million CNY | -9.02% |
| 2021 Q3 | 87.36 Million CNY | -3.83% |
| 2021 FY | 342.04 Million CNY | 14.22% |
| 2021 Q2 | 90.85 Million CNY | 17.7% |
| 2021 Q4 | 86.63 Million CNY | -0.84% |
| 2020 Q1 | 31.32 Million CNY | -63.81% |
| 2020 FY | 299.46 Million CNY | 0.76% |
| 2020 Q4 | 84.83 Million CNY | -13.96% |
| 2020 Q2 | 84.7 Million CNY | 170.44% |
| 2020 Q3 | 98.59 Million CNY | 16.4% |
| 2019 Q1 | 58.52 Million CNY | 0.0% |
| 2019 Q3 | 80.18 Million CNY | 11.41% |
| 2019 Q2 | 71.96 Million CNY | 22.98% |
| 2019 FY | 297.21 Million CNY | 16.96% |
| 2019 Q4 | 86.54 Million CNY | 7.93% |
| 2018 FY | 254.12 Million CNY | 16.97% |
| 2017 FY | 217.26 Million CNY | 9.5% |
| 2016 FY | 198.41 Million CNY | 0.0% |
| 2013 FY | 96.32 Million CNY | 37.58% |
| 2012 FY | 70.01 Million CNY | 22.94% |
| 2011 FY | 56.95 Million CNY | 0.0% |